NCT03952598
- Conditions
- Glioma, Gliomas, High Grade Glioma, +9 more
- Locations
-
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
Clinical trial condition
Neoplasms, Glandular and Epithelial
Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.
12,778 public trials
2,943 recruiting studies
Neoplasms, Glandular and Epithelial trial results
NCT05453799
- Conditions
- Carcinoma, Locally Advanced Thyroid Gland Anaplastic Carcinoma, Metastatic Thyroid Gland Anaplastic Carcinoma, +5 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
- M D Anderson Cancer Center Houston, Texas, United States
NCT04539366
- Conditions
- Neoplasms, Neoplasms by Histologic Type, Neoplasms, Bone Tissue, +20 more
- Locations
-
- Children's Hospital Los Angeles Los Angeles, California, United States
- Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States
- Children's Hospital Colorado Aurora, Colorado, United States
- National Institutes of Health Clinical Center Bethesda, Maryland, United States
NCT06671912
- Conditions
- Adenocarcinoma, Anatomic Stage 0 Breast Cancer AJCC v8, Anatomic Stage 1 Breast Cancer AJCC v8, +18 more
- Locations
-
- Katmai Oncology Group Anchorage, Alaska, United States
- Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
- CTCA at Western Regional Medical Center Goodyear, Arizona, United States
- Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
NCT06325683
- Conditions
- Astrocytoma, Glioblastoma, Glioma, +9 more
- Locations
-
- NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
- Sutter Auburn Faith Hospital Auburn, California, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- Kaiser Permanente Dublin Dublin, California, United States
NCT07660458
- Conditions
- Glioma, Medulloblastoma, Neoplasms, +8 more
- Locations
-
- West China Hospital of Sichuan University Chengdu, Sichuan, China
Withdrawn
89Zr-Panitumumab for Assessment of Suspected Metastatic Lesions on 18F-FDG-PET/CT in HNSCC
NCT05423197
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
- Locations
-
- Stanford Cancer Institute San Francisco, California, United States
Withdrawn
PDT Plus Vitamin D3 for Anal Dysplasia
NCT02698293
- Conditions
- Anal Dysplasia, Carcinoma, Carcinoma in Situ, +3 more
- Locations
-
- Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States